SUMMARY Fourteen preterm infants who developed bronchopulmonary dysplasia diagnosed radiologically were compared with a group of similar infants who did not. The two groups were of comparable maturity and birth weight. The clinical histories indicated that those infants with bronchopulmonary dysplasia had had longer periods of supplemental oxygen, more frequent treatment with dexamethasone, and a higher mean total dosage of frusemide.
Impaired skeletal mineral absorption is common in preterm infants after prolonged intensive care.' In such cases the deficit in bone mineral content (BMC) can be measured accurately by photon absorptiometry,2 and we have shown that at a postconceptional age of 40 weeks the deficit in BMC in the mid-forearm compared with that in the arms of full term infants measured at birth is about 20%. 4 Inability in postnatal life to match intrauterine skeletal mineral absorption may be exacerbated by several factors including prolonged intravenous nutrition with its inherent limitation on mineral intake5; fluid restriction, resulting in decreased intake of calcium and phosphorus; physiological losses of calcium and phosphorus in stool and urine, which limit the quantities retained; chronic acidosis6; and treatment with steroids7 and diuretics.8 These factors are more common in infants undergoing prolonged intensive care, who often develop bronchopulmonary dysplasia (BPD).
Although there have been reports of radiologically diagnosed bone disease occurring in conjunction with chronic neonatal lung disease,9 "I only once to our knowledge has its severity been measured by photon absorptiometry." As part of a larger study of bone mineral absoption in neonates we compared otherwise similar groups of preterm infants with and without BPD to ascertain whether undermineralisation was more severe in those with BPD.
Patients and methods
This retrospective study was confined to infants who had undergone photon absorptiometry of the forearm at or near the postconceptional age of 40 weeks. Informed consent was obtained from the parents and the study approved by the hospital ethical committee.
Over a period of 26 months 14 infants who needed ventilation for hyaline membrane disease developed radiological and clinical evidence of BPD. Using established criteria,'2 a paediatric radiologist (RA) graded their chest radiographs as showing either moderate or severe BPD. Fourteen infants of similar maturity and birth weight who were in the unit during the same period were identified and formed the control group; they were selected because they too had been ventilated but their chest radiographs showed either mild or no changes of BPD. Table 1 shows the sex, gestational age, birth weight, and duration of stay in the unit of each infant.
The number of days of ventilation and the number of days of supplemental oxygen were recorded for each infant. Table 2 gives these details together with the number of days of intravenous fluid replacement, acidosis (blood pH less than 7-30, usually respiratory in origin), and treatment with dexamethasone (0-1 mg/kg/dose) when these data were available. Only one infant in the control group 889 BMC in the mid-forearm was measured as previously described.2 4 Photon absorptiometry of the forearm in neonates entails a small skin entrance dose of 0-03 mGy (3 mrads) for each investigation; a 0-5 cm length of forearm is irradiated. The procedure was done in 24 of the infants at postconceptional ages ranging from 37 to 41 weeks, and the remaining four within six days of these limits. Results are expressed as mass of ash per unit length (mg/cm). Crown-heel length (cm), weight (g), and ulnar length (mm) were measured when photon absorptiometry was performed. Table 4 shows the results of the radiological grading for evidence of BPD, the results of photon absorptiometry, and anthropometric data. Blood samples were taken for assay of plasma concentrations of 25-hydroxyvitamin D from 18 of the 28 infants on the day that absorptiometry was performed.'3 These results are also shown in table 4.
When the data were normally distributed the mean, standard deviation (SD), and standard error (SE) of each measurement were computed for each group and the significance of the difference between the two group means calculated with the unpaired Student's t test. Otherwise only the means were calculated and a non-parametric test (MannWhitney U test or Wilcoxon rank sum test) used to calculate the significance of the differences between the two groups. Two tailed probabilities are quoted throughout.
Results
There were no significant differences in mean gestational age or birth weight between the infants received dexamethasone (for laryngeal oedema). with BPD and the controls (Table 1) . Those with Table 3 shows the number of doses of frusemide BPD spent significantly more time in the unit (1-2 mg/kg) given to each infant; treatment with (p < 0-02; table 1) and required more days of dexamethasone or frusemide, or both, was always ventilation (p < 0-001) and supplemental oxygen stopped before discharge from the unit.
(p < 0-001; table 2) than the controls. Intravenous Oral fluid intake was used to derive energy and fluid replacement was undertaken significantly more mineral intakes from manufacturers' data sheets. often (p < 0-01) and acidosis occurred more fre- Table 3 lists the total calcium intake with corres-quently (p < 0.005) in the group with BPD than in ponding mean daily intakes of fluid, energy, and the control group. Infants with BPD were treated calcium up to the day when photon absorptiometry more frequently with dexamethasone (p < 0-005; was performed. Fluid intake was unknown in two table 2); the mean total frusemide dosage was also cases. significantly higher (p < 0-05; table 3).
We always supplement the milk with vitamin D The mean total calciutm intake was significantly (400 or 1000 IU daily) once oral feeds can be lower in the group with BPD than in the control tolerated, and vitamin D intake is usually recorded group (6-46 g v 10-33 g; p < 0-05; table 3). The throughout each infant's stay in the unit, the mean mean daily calcium intake in the group with BPD (expressed as mmol/kg/day) was also lower but not significantly so. Daily fluid and energy intakes were significantly lower in the group with BPD than in the control group (p < 0-02 and p < 0-05, respectively).
The group with BPD had a lower mean vitamin D intake than the control group (306 v 472 IU daily); this difference was significant (p < 0.05). The mean plasma 25-hydroxyvitamin D concentrations around the postconceptional age of 40 weeks were comparable and not significantly different between the two groups; in the group with BPD one infant had a value below 25 nmol/l whereas four controls had values below that limit.
At about 40 weeks the infants with BPD were on average lighter than the controls (table 4) ; the difference (about 430 g) between the group means was significant (p < 0-05). There were no significant differences between the two groups in mean crownheel length, ulnar length, or BMC. Even when the extreme cases were contrasted the mean BMC did not differ significantly between those with and without BPD; mean (SE) BMC in nine infants classified as having severe radiological changes associated with BPD was 98-0 (5-5) mg/cm, and in 10 controls with no radiological evidence of BPD the corresponding value was 105-1 (11-4) mg/cm. Although significant differences between groups could not be shown, the mean BMC was only about 100 mg/cm in both the BPD and control groups; in contrast, the mean value in full term infants measured at birth with the same apparatus has been shown to be 194-0 (3-7) mg/cm.4
Discussion
During pregnancy the placenta provides the fetus with a readily available source of calcium and phosphorus. It has been estimated that the accretion of calcium in utero is about 130 mg/kg/day during Although skeletal changes associated with neonatal bone disease can sometimes be detected radiologically,15 the more sensitive technique of photon absorptiometry has shown that the bones of almost all premature infants are deficient in minerals by the time they reach the postconceptional age of 40 weeks. -3 There are compelling theoretical reasons for believing that inadequate skeletal mineralisation should be more pronounced in infants who develop BPD. As we have shown, these infants are generally more ill and require longer periods of ventilation and supplemental oxygen with restriction of fluids, and hence lower calcium and phosphorus intakes. Although we did not attempt to carry out balance studies, in both the BPD and control groups the average daily calcium intake over the study period was far less than would be expected in utero. Furthermore, the calcium available for absorption into bone was considerably less than the intake because retention was probably no more than 50%.16 Calcium retention in the group with BPD was probably further reduced by treatment with The results of this study indicate that the skeleton is deficient in minerals in infants with BPD as a consequence of their prematurity. That such infants were not found to be more severely undermineralised than preterm controls without BPD was surprising. Both mineral and vitamin D intakes in preterm infants may be suboptimal during their stay in the neonatal unit, and both factors probably contribute to the development of neonatal bone disease, although the grossly deficient mineral intake (compared with the intrauterine accretion) may be the more important. 17 It is reassuring to know that the current treatment of BPD with frusemide and dexamethasone does not seem to be detrimental. 9 JRJ has a research grant from the Yorkshire Regional lealth Authority. SR is supported by an award from the special trustees of the General Infirmary, Leeds. We thank E B Mawer for performing the vitamin D assays. 
